VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to announce William (Bill) R. Corl has joined the board of directors of the Company. Mr. Corl is the Chief Executive Officer for Omega Laboratories, Inc., (“Omega”) one of the leading advanced specimen drug testing laboratories in the world. Omega and Cannabix have been working together since May 2024 under a strategic partnership and ...

VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the Canadian Intellectual Property Office (CIPO) has issued a notice of allowance for patent application No. 3243445 entitled, “Contact-Free Breath Analysis Device and Method” to the Company. Recently the U.S. Patent and Trademark Office issued a notice of allowance for the same patent application filed in the United Sta ...

Core Points - Cannabix Technologies Inc. has received a notice of allowance for its patent application regarding a "Contact-Free Breath Analysis Device and Method" from the United States Patent and Trademark Office [1][3] - The technology involves dual mode contactless and traditional mouthpiece breath capture and analysis, applicable in various environments such as vehicles and workplaces, enabling fast and reliable testing without physical contact [2][3] - This patent application enhances Cannabix's position in breath sampling and detection techniques, contributing to its intellectual property portfolio [3] Company Overview - Cannabix Technologies Inc. specializes in developing marijuana and alcohol breath testing technologies for workplaces and law enforcement, focusing on recent marijuana use detection [4] - The company has developed the BreathLogix autonomous alcohol screening device aimed at improving alcohol safety and monitoring in organizations [4]